[PRESS RELEASE] – CALGARY, Alberta, May 11, 2026 – High Tide Inc., the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced that certain officers, directors and consultants, led by the company's president and CEO (together, the "insiders"), in the aggregate, acquired 90,882 common shares in the capital of High Tide on the open market between May 6 and May 8, 2026, at an average price of $3.39 per common share.
The purchase of common shares by the insiders reflects confidence in the intrinsic value of the stock and the near-term and long-term growth prospects of the company. With these purchases, insiders and certain consultants, in the aggregate, now own or control 7,720,360 common shares, representing approximately 8.8% of the company's issued and outstanding common shares as of May 11.
"Over the last week, High Tide has continued to demonstrate why we believe we are one of the strongest operators in the global cannabis industry,” High Tide founder and CEO Raj Grover said. “We secured a new senior lending relationship with a Big 5 Canadian bank through a $40 million credit facility term sheet, reported record quarterly medical cannabis distribution volumes at Remexian, and completed a highly productive institutional investor roadshow across three cities. In addition, newly released BfArM Q1 2026 data indicates that Remexian's market share in Germany has risen to over 14%, more than doubling its share since our transaction, and further validating the strength of our international strategy.
"I am very pleased to have increased my own ownership position alongside several members of our board and leadership team following these developments. We believe the operational momentum across our retail platform, international business and balance sheet continues to strengthen, and these insider purchases reflect our confidence in the long-term value we are building.”
